Tirzepatide, a dual GLP-1 and GIP receptor agonist, changes how your body responds to hunger and digestion
These drugs are often paired with other treatments, and knowing how they work together is key to ensuring cardiovascular safety
The affected area may feel warm, swollen, or increasingly sensitive to touch
You can read the full AMA discussion on Reddit here
Gradual dose titration significantly reduces the incidence and severity of gastrointestinal symptoms
Ozempic (Semaglutide): Key Differences Both Tirzepatide (Mounjaro) and Semaglutide (Ozempic) are effective medications for weight loss, but they have some differences: Mechanism of Action: Tirzepatide activates both GIP and GLP-1 receptors, while Semaglutide primarily activates GLP-1 receptors